Clinical Trials in Houston

Showing 921-940 of 8,625 trials

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

NCT04005976

The Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenotype associated with these genes, and determine genetic and environmental modifiers of H-TAD.

Aortic AneurysmAortic DissectionAortic Diseases

The University of Texas Health Science Center, Houston5,000 participantsStarted Jun 2016

Newport Beach, California, United States • Newport Beach, California, United States • Sacramento, California, United States +17 more locations

RECRUITINGNA< 1 mile

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

NCT06891755

The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the treatment of adult COPD patients with emphysema suffering from dyspnea due to hyperinflation despite optimal medical treatment. The Apreo BREATHE Airway Scaffold is a permanent implant designed to tent open native airways. The study will include up to 250 participants at up to 25 study centers located in the United States and Europe. Study subjects will be followed for 3 years. The main questions it aims to answer are: Is it safe? Does it work?

COPDEmphysema

Apreo Health, Inc.250 participantsStarted Jul 2025

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Sacramento, California, United States +16 more locations

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Find Trials by Condition in Houston

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Examining a Wheelchair Exercise-training Intervention for Persons With Multiple Sclerosis

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Effect of Vitamin D in Diets of Preterm Infants

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

R-3750 in Patients With Mild to Moderate Ulcerative Colitis